Who
WALTERS GROUP
10% owner
Company insider
Files Form 4 as: 10% owner, Zentalis Pharmaceuticals.
In numbers
- Trades disclosed
- 2
- Buys
- 2
- Sells
- 0
- Bought
- $22.9M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Dec 2025
- Last trade
- 14 Aug 2026
- Last filed
- 19 Aug 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 19 Aug 2026 | ZNTL Zentalis PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $15.2M4,335,000 at $3.50 | filing |
| 31 Dec 2025filed 8 Jan 2026 | ZNTL Zentalis PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $7.8M6,459,973 at $1.20 | filing |
News
Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 AbstractZNTL · manilatimes.net · 18 Oct 2026
0 headlines in the last 90 days name WALTERS GROUP; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.